Skip to main content
OpenTrials

Clinical trial condition

Urothelial Carcinoma

Explore clinical trials studying Urothelial Carcinoma. Study availability and eligibility vary by location and protocol.

239 public trials 74 recruiting studies
Refine in advanced search Browse all conditions

Urothelial Carcinoma trial results

Recruiting

A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

NCT06695845

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +64 more
Locations
  • Arizona Oncology Associates, PC - NAHOA Prescott, Arizona, United States
  • Rocky Mountain Cancer Center Littleton, Colorado, United States
  • Florida Cancer Specialists - South Fort Myers, Florida, United States
  • Florida Cancer Specialists - Lake Nona Orlando, Florida, United States
View all 28 locations
View Trial Details
Recruiting

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors

NCT05581004

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +57 more
Locations
  • Stanford University San Francisco, California, United States
  • University Of Colorado Aurora, Colorado, United States
  • Florida Cancer Specialists - Sarasota Sarasota, Florida, United States
  • Winship Cancer Institute Atlanta, Georgia, United States
View all 41 locations
View Trial Details
Recruiting

A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors

NCT07169734

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Transitional Cell, +19 more
Locations
  • Mayo Clinic Comprehensive Cancer Center Phoenix, Arizona, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Yale Comprehensive Cancer Center New Haven, Connecticut, United States
  • The University of Chicago Medical Center - Oncology Chicago, Illinois, United States
View all 41 locations
View Trial Details
Recruiting

A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

NCT04895709

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Diseases, +56 more
Locations
  • Community Cancer Institute Clovis, California, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • University of Iowa Iowa City, Iowa, United States
View all 47 locations
View Trial Details
Recruiting

A Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer

NCT07532902

Conditions
Carcinoma, Carcinoma, Transitional Cell, Diffuse Pleural Mesothelioma, +5 more
Locations
  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer

NCT06774131

Conditions
Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +4 more
Locations
  • Urology Centers of Alabama Homewood, Alabama, United States
  • Arizona State Urological Research Institute, LLC ("ASURI") Chandler, Arizona, United States
  • East Valley Urology Center of Arizona Queen Creek, Arizona, United States
  • University of Arkansas for Medical Sciences Arkansas City, Arkansas, United States
View all 62 locations
View Trial Details
Recruiting

A Study of GEN1106 in Participants With Solid Tumors

NCT07416123

Conditions
Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +4 more
Locations
  • Yale Cancer Center New Haven, Connecticut, United States
  • START New York Long Island LLC Lake Success, New York, United States
  • Carolina Urologic Research Center Myrtle Beach, South Carolina, United States
  • South Texas Accelerated Research Therapeutics San Antonio, Texas, United States
View Trial Details

Related conditions